{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:49:03Z","timestamp":1793692143495,"version":"4.5.1"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119622","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:16:46Z","timestamp":1781461006000},"page":"119622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases"],"prefix":"10.1016","volume":"201","author":[{"given":"Khojaste Rahimi","family":"Jaberi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Rohani","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Aligholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-4127","authenticated-orcid":false,"given":"Sara","family":"Takallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Rahimi","family":"Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119622_bib1","first-page":"1","article-title":"Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment","author":"Pathak","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2026.119622_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"12","key":"10.1016\/j.biopha.2026.119622_bib3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119622_bib5","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.3390\/ijms22073742","article-title":"Disease-induced modulation of drug transporters at the blood\u2013brain barrier level","volume":"22","author":"Al Rihani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/187152709788680652","article-title":"Blood-brain barrier transport of drugs for the treatment of brain diseases","volume":"8","author":"Gabathuler","year":"2009","journal-title":"CNS & Neurol. Disord. -Drug. Targets-CNS & Neurol. Disord."},{"issue":"17","key":"10.1016\/j.biopha.2026.119622_bib8","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.7150\/thno.24512","article-title":"MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain","volume":"8","author":"Kovacs","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119622_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood\u2013brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-020-00418-z","article-title":"Applications of focused ultrasound in the brain: from thermoablation to drug delivery","volume":"17","author":"Meng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119622_bib11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2022.1375","article-title":"Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial","volume":"79","author":"Teng","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biopha.2026.119622_bib12","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1007\/s00330-020-06712-0","article-title":"Intraoperative imaging findings in transcranial MR imaging-guided focused ultrasound treatment at 1.5 T may accurately detect typical lesional findings correlated with sonication parameters","volume":"30","author":"Gagliardo","year":"2020","journal-title":"Eur. Radiol."},{"issue":"46","key":"10.1016\/j.biopha.2026.119622_bib13","doi-asserted-by":"crossref","first-page":"81001","DOI":"10.18632\/oncotarget.20944","article-title":"PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2026.119622_bib14","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1121\/1.3646905","article-title":"The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice","volume":"130","author":"Tung","year":"2011","journal-title":"J. Acoust. Soc. Am."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib15","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaa30d","article-title":"Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery","volume":"63","author":"Wu","year":"2018","journal-title":"Phys. Med. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119622_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1300962","article-title":"A pilot study of focused ultrasound thalamotomy for essential tremor","volume":"369","author":"Elias","year":"2013","journal-title":"New. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119622_bib17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.21801","article-title":"High-intensity focused ultrasound for noninvasive functional neurosurgery","volume":"66","author":"Martin","year":"2009","journal-title":"Ann. Neurol."},{"issue":"7, Pt 2","key":"10.1016\/j.biopha.2026.119622_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1540-8175.1999.tb00143.x","article-title":"Interaction of Microbubbles with Ultrasound","volume":"16","author":"Von Bibra","year":"1999","journal-title":"Echocardiogr. (Mt. Kisco NY)"},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brs.2011.03.007","article-title":"A review of low-intensity focused ultrasound pulsation","volume":"4","author":"Bystritsky","year":"2011","journal-title":"Brain Stimul."},{"key":"10.1016\/j.biopha.2026.119622_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119622_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","article-title":"Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system","volume":"72","author":"Aryal","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1148\/radiol.2271020395","article-title":"MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study","volume":"226","author":"Tempany","year":"2003","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.biopha.2026.119622_bib23","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/01.RVI.0000092900.73329.A2","article-title":"Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma","volume":"14","author":"Gianfelice","year":"2003","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"issue":"4","key":"10.1016\/j.biopha.2026.119622_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.mric.2024.04.005","article-title":"MR-guided Focused Ultrasound Thalamotomy for Chronic Pain","volume":"32","author":"Colasurdo","year":"2024","journal-title":"Magn. Reson. Imaging Clin. North. Am."},{"key":"10.1016\/j.biopha.2026.119622_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biopha.2026.119622_bib26","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1121\/1.3646905","article-title":"The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice","volume":"130","author":"Tung","year":"2011","journal-title":"J. Acoust. Soc. Am."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31071-8","article-title":"Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhances GSK-3 Inhibitor Delivery for Amyloid-Beta Plaque Reduction","volume":"8","author":"Hsu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119622_bib28","article-title":"Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders","volume":"86","author":"Raghav","year":"2023","journal-title":"J. Drug. Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119622_bib29","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMoa1600159","article-title":"A randomized trial of focused ultrasound thalamotomy for essential tremor","volume":"375","author":"Elias","year":"2016","journal-title":"New. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.10090699","article-title":"Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment","volume":"255","author":"Liu","year":"2010","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acsami.1c22803","article-title":"Recent Trend of Ultrasound-Mediated Nanoparticle Delivery for Brain Imaging and Treatment","volume":"15","author":"Jo","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pharmaceutics13010015","article-title":"Focused ultrasound and microbubbles-mediated drug delivery to brain tumor","volume":"13","author":"Wu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119622_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/11533070-000000000-00000","article-title":"Intravenous immunoglobulins as a treatment for Alzheimer\u2019s disease: rationale and current evidence","volume":"70","author":"Dodel","year":"2010","journal-title":"Drugs"},{"issue":"374","key":"10.1016\/j.biopha.2026.119622_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119622_bib35","doi-asserted-by":"crossref","unstructured":"Ediriweera G.R., Fletcher N.L., Cowin G., Simpson J.D., Chen L., Wasielewska J.M., et al. Enhancing the delivery of SOD1 antisense oligonucleotides to the murine brain using lipid nanoparticles and image-guided focused ultrasound. 2022.","DOI":"10.21203\/rs.3.rs-1640138\/v1"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s44337-024-00093-9","article-title":"Chitosan nanoparticle encapsulation improves the effect of donepezil on impaired memory in an amnesia mouse model","volume":"1","author":"Heidari","year":"2024","journal-title":"Discov. Med."},{"issue":"8","key":"10.1016\/j.biopha.2026.119622_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMoa1600159","article-title":"A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor","volume":"375","author":"Elias","year":"2016","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119622_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027877","article-title":"Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier","volume":"6","author":"Burgess","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2026.119622_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/616197","article-title":"MRI-Guided Focused Ultrasound as a New Method of Drug Delivery","volume":"2013","author":"Thanou","year":"2013","journal-title":"J. Drug. Deliv."},{"issue":"1-3","key":"10.1016\/j.biopha.2026.119622_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.pbiomolbio.2006.07.019","article-title":"Ultrasound, microbubbles and the blood\u2013brain barrier","volume":"93","author":"Meairs","year":"2007","journal-title":"Progress. Biophys. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroimage.2004.06.046","article-title":"Local and reversible blood\u2013brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications","volume":"24","author":"Hynynen","year":"2005","journal-title":"Neuroimage"},{"issue":"43","key":"10.1016\/j.biopha.2026.119622_bib44","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/acsami.1c22803","article-title":"Recent trend of ultrasound-mediated nanoparticle delivery for brain imaging and treatment","volume":"15","author":"Jo","year":"2022","journal-title":"ACS Appl. Mater. & Interfaces"},{"issue":"9","key":"10.1016\/j.biopha.2026.119622_bib46","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.ultrasmedbio.2021.04.027","article-title":"Designed Ankyrin repeat proteins as novel binders for ultrasound molecular imaging","volume":"47","author":"Kosareva","year":"2021","journal-title":"Ultrasound Med. & Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119622_bib47","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.101","article-title":"Noninvasive delivery of an \u03b1-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound","volume":"33","author":"Xhima","year":"2018","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib50","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41467-021-21022-9","article-title":"Blood-brain barrier opening with focused ultrasound in Parkinson\u2019s disease dementia","volume":"12","author":"Gasca-Salas","year":"2021","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2026.119622_bib51","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.3390\/pharmaceutics14122607","article-title":"Cavitation feedback control of focused ultrasound blood-brain barrier opening for drug delivery in patients with Parkinson\u2019s disease","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMoa2308719","article-title":"Ultrasound blood\u2013brain barrier opening and aducanumab in Alzheimer\u2019s disease","volume":"390","author":"Rezai","year":"2024","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17340\/jkna.2019.1.1","article-title":"A New Biological Definition of Alzheimer\u2019s Disease: Introduction of 2018 National Institute on Aging-Alzheimer\u2019s Association Research Framework","volume":"37","author":"Jang","year":"2019","journal-title":"J. Korean Neurol. Assoc."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119622_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug. Discov. Today"},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s13534-017-0025-4","article-title":"Biological effects of blood\u2013brain barrier disruption using a focused ultrasound","volume":"7","author":"Han","year":"2017","journal-title":"Biomed. Eng. Lett."},{"key":"10.1016\/j.biopha.2026.119622_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-45","article-title":"Microglial phagocytosis induced by fibrillar \u03b2-amyloid is attenuated by oligomeric \u03b2-amyloid: implications for Alzheimer's disease","volume":"6","author":"Pan","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2026.119622_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37533","article-title":"A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer\u2019s disease","author":"Rouhi","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119622_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jconrel.2021.06.037","article-title":"Focused ultrasound with anti-pGlu3 A\u03b2 enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells","volume":"336","author":"Sun","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17425247.2024.2438188","article-title":"Advancements in ultrasound-mediated drug delivery for central nervous system disorders","volume":"22","author":"Chuang","year":"2025","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"ement_1","key":"10.1016\/j.biopha.2026.119622_bib60","article-title":"Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound","volume":"66","author":"Meng","year":"2019","journal-title":"Neurosurgery"},{"issue":"374","key":"10.1016\/j.biopha.2026.119622_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12968\/ijap.2024.2.1.20","article-title":"A case study exploration of Parkinson's disease","volume":"2","author":"Mark","year":"2024","journal-title":"Int. J. Adv. Pract."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib63","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2202001804","article-title":"Noninvasive MR imaging\u2013guided focal opening of the blood-brain barrier in rabbits","volume":"220","author":"Hynynen","year":"2001","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.biopha.2026.119622_bib64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib65","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3340\/jkns.2022.0236","article-title":"Characteristics of Focused Ultrasound Mediated Blood-Brain Barrier Opening in Magnetic Resonance Images","volume":"66","author":"Chang","year":"2023","journal-title":"J. Korean Neurosurg. Soc."},{"issue":"20","key":"10.1016\/j.biopha.2026.119622_bib66","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","article-title":"Safety and tolerability of putaminal AADC gene therapy for Parkinson disease","volume":"73","author":"Christine","year":"2009","journal-title":"Neurology"},{"issue":"6512","key":"10.1016\/j.biopha.2026.119622_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119622_bib68","unstructured":"Er S. GDNF\/RET signaling and its downstream pathways eliminate alpha-synuclein pathology in dopamine neurons. 2023."},{"key":"10.1016\/j.biopha.2026.119622_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.846681","article-title":"Neurotrophins as therapeutic agents for Parkinson\u2019s disease; new chances from focused ultrasound?","volume":"16","author":"Stefani","year":"2022","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0165-0173(01)00098-4","article-title":"Sustained delivery of GDNF: towards a treatment for Parkinson\u2019s disease","volume":"36","author":"Zurn","year":"2001","journal-title":"Brain Res. Rev."},{"issue":"343","key":"10.1016\/j.biopha.2026.119622_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6086","article-title":"Clinical trial of blood-brain barrier disruption by pulsed ultrasound","volume":"8","author":"Carpentier","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib72","first-page":"195","article-title":"Gene therapy for Parkinson\u2019s disease, an update","volume":"8","author":"Axelsen","year":"2018","journal-title":"J. Park. \u2019S. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40263-019-00695-3","article-title":"Recent advances in the treatment of Huntington\u2019s disease: targeting DNA and RNA","volume":"34","author":"Shannon","year":"2020","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.biopha.2026.119622_bib74","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ultrasmedbio.2023.02.017","article-title":"Current and emerging systems for focused ultrasound-mediated blood\u2013brain barrier opening","volume":"49","author":"Hughes","year":"2023","journal-title":"Ultrasound Med. & Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2012.08.012","article-title":"Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression","volume":"163","author":"Burgess","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119622_bib76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-3-319-22536-4_16","article-title":"Microbubble-assisted ultrasound for drug delivery in the brain and central nervous system","author":"Burgess","year":"2016","journal-title":"Ther. Ultrasound"},{"issue":"37","key":"10.1016\/j.biopha.2026.119622_bib77","doi-asserted-by":"crossref","first-page":"E8717","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood\u2013tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119622_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"9769","key":"10.1016\/j.biopha.2026.119622_bib79","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"lancet"},{"issue":"5","key":"10.1016\/j.biopha.2026.119622_bib80","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119622_bib81","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fonc.2018.00338","article-title":"Low-intensity MR-guided focused ultrasound mediated disruption of the blood-brain barrier for intracranial metastatic diseases","volume":"8","author":"Meng","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119622_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1507940","article-title":"Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma","volume":"15","author":"Holman","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib83","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1574888X10666150902095031","article-title":"Mesenchymal stem cells in the treatment of amyotrophic lateral sclerosis","volume":"11","author":"Hajivalili","year":"2016","journal-title":"Curr. Stem Cell. Res. & Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib84","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11033-025-10333-5","article-title":"Low-intensity pulsed ultrasound promotes proliferation and differentiation of neural stem cells to enhance spinal cord injury recovery","volume":"52","author":"Liao","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib85","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11095-022-03185-2","article-title":"Focused ultrasound-mediated drug delivery in humans\u2013a path towards translation in neurodegenerative diseases","volume":"39","author":"Wasielewska","year":"2022","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.biopha.2026.119622_bib86","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol."},{"issue":"14","key":"10.1016\/j.biopha.2026.119622_bib87","doi-asserted-by":"crossref","first-page":"e1391","DOI":"10.1212\/WNL.0000000000207663","article-title":"Randomized phase II study of the safety and efficacy of semorinemab in participants with mild-to-moderate Alzheimer disease: Lauriet","volume":"101","author":"Monteiro","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","article-title":"Multiple system atrophy","volume":"3","author":"Wenning","year":"2004","journal-title":"Lancet Neurol."},{"issue":"13-14","key":"10.1016\/j.biopha.2026.119622_bib89","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.addr.2013.08.004","article-title":"Nanopreparations to overcome multidrug resistance in cancer","volume":"65","author":"Patel","year":"2013","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2026.119622_bib90","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41565-025-01990-5","article-title":"Acoustically activatable liposomes as a translational nanotechnology for site-targeted drug delivery and noninvasive neuromodulation","volume":"20","author":"Purohit","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molmed.2023.12.006","article-title":"Focused ultrasound gene delivery for the treatment of neurological disorders","volume":"30","author":"Kofoed","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"33","key":"10.1016\/j.biopha.2026.119622_bib92","doi-asserted-by":"crossref","first-page":"35463","DOI":"10.1021\/acsomega.4c02140","article-title":"Development of epigallocatechin and ascorbic acid dual delivery transferosomes for managing Alzheimer\u2019s disease: in vitro and in vivo studies","volume":"9","author":"Mishra","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2026.119622_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100204","article-title":"Drug delivery strategies to cross the blood-brain barrier in Alzheimer\u2019s disease: a comprehensive review on three promising strategies","author":"de Koning","year":"2025","journal-title":"J. Prev. Alzheimer's. Dis."},{"key":"10.1016\/j.biopha.2026.119622_bib94","series-title":"Nanoarchitectonics for brain drug delivery","author":"Singh","year":"2024"},{"key":"10.1016\/j.biopha.2026.119622_bib95","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3389\/fphar.2019.01348","article-title":"Recent advances in the use of focused ultrasound for magnetic resonance image-guided therapeutic nanoparticle delivery to the central nervous system","volume":"10","author":"Fisher","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119622_bib96","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jconrel.2023.12.008","article-title":"Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin","volume":"365","author":"Andrianopoulou","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17425247.2024.2438188","article-title":"Advancements in ultrasound-mediated drug delivery for central nervous system disorders","volume":"22","author":"Chuang","year":"2025","journal-title":"Expert. Opin. Drug. Deliv."},{"issue":"32","key":"10.1016\/j.biopha.2026.119622_bib98","doi-asserted-by":"crossref","first-page":"9720","DOI":"10.1039\/D5TB00911A","article-title":"Recent advances in NIR-II emitting nanomaterials: design and biomedical applications of lanthanide complexes and functionalized mesoporous silica nanoparticles (MSNs)","volume":"13","author":"Bandyopadhyay","year":"2025","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"10.1016\/j.biopha.2026.119622_bib99","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1021\/acsbiomaterials.1c00514","article-title":"Lipid-coated MCM-41 mesoporous silica nanoparticles loaded with berberine improved inhibition of acetylcholine esterase and amyloid formation","volume":"7","author":"Singh","year":"2021","journal-title":"ACS Biomater. Sci. & Eng."},{"issue":"9","key":"10.1016\/j.biopha.2026.119622_bib100","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1039\/D3NA01142A","article-title":"vitro profiling and molecular dynamics simulation studies of berberine loaded MCM-41 mesoporous silica nanoparticles to prevent neuronal apoptosis","volume":"6","author":"Singh","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib101","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acsabm.0c01319","article-title":"Dendrimer architectonics to treat cancer and neurodegenerative diseases with implications in theranostics and personalized medicine","volume":"4","author":"Moorthy","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"12","key":"10.1016\/j.biopha.2026.119622_bib102","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1039\/D4MA01215A","article-title":"Applications of bionanomaterials in neurodegenerative diseases","volume":"6","author":"Biswas","year":"2025","journal-title":"Mater. Adv."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib103","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/acsomega.8b03445","article-title":"Dendrimer donepezil conjugates for improved brain delivery and better in vivo pharmacokinetics","volume":"4","author":"Singh","year":"2019","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/03639045.2019.1698594","article-title":"Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil","volume":"46","author":"Singh","year":"2020","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2026.119622_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2023.102678","article-title":"Nanoscale metal-organic framework delivers rapamycin to induce tissue immunogenic cell death and potentiates cancer immunotherapy","volume":"50","author":"Tian","year":"2023","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119622_bib106","article-title":"Hybrid transferosomes as multifunctional nanocarriers for enhanced targeted therapy and theranostic drug delivery in complex diseases","volume":"115","author":"Keerikkadu","year":"2026","journal-title":"J. Drug. Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31071-8","article-title":"Focused ultrasound-induced blood-brain barrier opening enhances GSK-3 inhibitor delivery for amyloid-beta plaque reduction","volume":"8","author":"Hsu","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib108","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/pharmaceutics16010051","article-title":"Effect of phase-change nanodroplets and ultrasound on blood\u2013brain barrier permeability in vitro","volume":"16","author":"Vlatakis","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.biopha.2026.119622_bib109","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1039\/D1NR07882H","article-title":"Phase-shift nanodroplets as an emerging sonoresponsive nanomaterial for imaging and drug delivery applications","volume":"14","author":"Zhang","year":"2022","journal-title":"Nanoscale"},{"issue":"9","key":"10.1016\/j.biopha.2026.119622_bib110","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/neuonc\/noae087","article-title":"Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasound","volume":"26","author":"Piper","year":"2024","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.biopha.2026.119622_bib111","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jconrel.2024.10.023","article-title":"Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier opening","volume":"376","author":"Dauba","year":"2024","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.biopha.2026.119622_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37533","article-title":"A comprehensive review of advanced focused ultrasound (FUS) microbubbles-mediated treatment of Alzheimer's disease","volume":"10","author":"Rouhi","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-67916-8","article-title":"Comprehensive assessment of blood\u2013brain barrier opening and sterile inflammatory response: unraveling the therapeutic window","volume":"14","author":"Martinez","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jneumeth.2004.04.026","article-title":"Method for measurement of the blood\u2013brain barrier permeability in the perfused mouse brain: application to amyloid-\u03b2 peptide in wild type and Alzheimer\u2019s Tg2576 mice","volume":"138","author":"LaRue","year":"2004","journal-title":"J. Neurosci. Methods"},{"issue":"4","key":"10.1016\/j.biopha.2026.119622_bib115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1006\/nbdi.2001.0402","article-title":"Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease","volume":"8","author":"Poduslo","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11095-022-03185-2","article-title":"Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases","volume":"39","author":"Wasielewska","year":"2022","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-8118-10-6","article-title":"The brain slice method for studying drug distribution in the CNS","volume":"10","author":"Loryan","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24321","article-title":"Financial efficiency and CO2 emission in BRICS. Dose digital economy development matter?","volume":"10","author":"Mngumi","year":"2024","journal-title":"Heliyon"},{"issue":"2-3","key":"10.1016\/j.biopha.2026.119622_bib119","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0165-0173(01)00098-4","article-title":"Sustained delivery of GDNF: towards a treatment for Parkinson\u2019s disease","volume":"36","author":"Zurn","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.biopha.2026.119622_bib120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jconrel.2022.08.012","article-title":"Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards","volume":"350","author":"Zain","year":"2022","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib121","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1570159X19666210823103020","article-title":"PLGA-based curcumin delivery system: An interesting therapeutic approach in the treatment of Alzheimer\u2019s disease","volume":"20","author":"Shahbaz","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib122","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","article-title":"Blood\u2013brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound","volume":"9","author":"Lipsman","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2026.119622_bib123","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/mds.27675","article-title":"Parkinson\u2019s disease gene therapy: will focused ultrasound and nanovectors be the next frontier?","volume":"34","author":"Price","year":"2019","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"issue":"13","key":"10.1016\/j.biopha.2026.119622_bib124","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1158\/1078-0432.CCR-18-3643","article-title":"Safety and feasibility of repeated and transient blood\u2013brain barrier disruption by pulsed ultrasound in patients with recurrent glioblastoma","volume":"25","author":"Idbaih","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"824","key":"10.1016\/j.biopha.2026.119622_bib125","article-title":"Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma","volume":"17","author":"Englander","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119622_bib126","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1007\/s00330-020-06712-0","article-title":"Intraoperative imaging findings in transcranial MR imaging-guided focused ultrasound treatment at 1.5 T may accurately detect typical lesional findings correlated with sonication parameters","volume":"30","author":"Gagliardo","year":"2020","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib127","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s44384-025-00024-7","article-title":"Imaging strategies to assess efficacy and safety of ultrasound-induced blood-brain barrier opening","volume":"1","author":"Pag\u00e9","year":"2025","journal-title":"npj Acoust."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib128","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1093\/neuros\/nyy480","article-title":"Convection-enhanced delivery of muscimol in patients with drug-resistant epilepsy","volume":"85","author":"Heiss","year":"2019","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11095-022-03185-2","article-title":"Focused ultrasound-mediated drug delivery in humans\u2013a path towards translation in neurodegenerative diseases","volume":"39","author":"Wasielewska","year":"2022","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib130","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaa30d","article-title":"Focused ultrasound-facilitated brain drug delivery using optimized nanodroplets: vaporization efficiency dictates large molecular delivery","volume":"63","author":"Wu","year":"2018","journal-title":"Phys. Med. & Biol."},{"key":"10.1016\/j.biopha.2026.119622_bib131","series-title":"Nanomedicine: Innovations, Applications, and Breakthroughs in the Quest for Health and Medicine's Future","first-page":"15","article-title":"Navigating safety and toxicity challenges in nanomedicine: strategies, assessment, and mitigation","author":"Kumar","year":"2024"},{"key":"10.1016\/j.biopha.2026.119622_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2025.107446","article-title":"A novel ultrasound-responsive cluster bomb system for efficient siRNA delivery in brain","volume":"120","author":"Guo","year":"2025","journal-title":"Ultrason. Sonochem."},{"issue":"4_ement","key":"10.1016\/j.biopha.2026.119622_bib133","doi-asserted-by":"crossref","first-page":"A213","DOI":"10.1121\/10.0037923","article-title":"Machine learning-assisted closed-loop focused ultrasound for targeted nanoparticle delivery and liquid biopsy in the brain","volume":"157","author":"Lee","year":"2025","journal-title":"J. Acoust. Soc. Am."},{"key":"10.1016\/j.biopha.2026.119622_bib134","unstructured":"Zhao L., Bai J., Bian Z., Chen Q., Li Y., Li G., et al. Autonomous multi-modal llm agents for treatment planning in focused ultrasound ablation surgery. arXiv preprint arXiv:250521418. 2025."},{"key":"10.1016\/j.biopha.2026.119622_bib135","article-title":"AI-Driven and 3D-Bioprinted New Approach Methodology (NAM) Identifies NEO100 as Potent Ultrasound-Activated Therapeutic for Primary and Metastatic Brain Tumors","author":"Majumder","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.biopha.2026.119622_bib136","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.brs.2025.10.006","article-title":"A multifunctional theranostic ultrasound platform for remote magnetogenetics and expanded blood-brain barrier opening","volume":"18","author":"Batts","year":"2025","journal-title":"Brain Stimul."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib137","first-page":"1","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2026.119622_bib138","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.wneu.2020.08.052","article-title":"Innovative applications of MR-guided focused ultrasound for neurological disorders","volume":"145","author":"Stavarache","year":"2021","journal-title":"World Neurosurg."},{"issue":"1","key":"10.1016\/j.biopha.2026.119622_bib139","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1038\/s41467-024-48326-w","article-title":"Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas","volume":"15","author":"Arrieta","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.119622_bib140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00280-015-2926-1","article-title":"Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes","volume":"77","author":"Lin","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119622_bib141","article-title":"Enhanced delivery to brain using sonosensitive liposome and microbubble with focused ultrasound","volume":"141","author":"Moon","year":"2022","journal-title":"Biomater. Adv."},{"issue":"3","key":"10.1016\/j.biopha.2026.119622_bib142","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jconrel.2012.02.023","article-title":"Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme","volume":"160","author":"Yang","year":"2012","journal-title":"J. Control. Release"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600658X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600658X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:33:55Z","timestamp":1784529235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600658X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":142,"alternative-id":["S075333222600658X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119622","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119622"}}